Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
J. Schouten(Neurology, Inc), W. Mulder(Unknown), Peter Reiss(Amsterdam Institute for Global Health and Development), Marieke Martens(Amsterdam UMC Location University of Amsterdam), Y M C Ruijs(Amsterdam University Medical Centers), A M Harskamp-Holwerda(Amsterdam UMC Location University of Amsterdam), W Zikkenheiner(Amsterdam UMC Location University of Amsterdam), Elisabeth van Leeuwen, Irma Maurer, Katherine W. Kooij(Amsterdam UMC Location University of Amsterdam), C. S. M. Jansen-Kok(Amsterdam UMC Location University of Amsterdam), S Zaheri(Stichting HIV Monitoring), Maria Prins(University of Amsterdam), F R Janssen(Amsterdam UMC Location University of Amsterdam), Jan M. Prins(Amsterdam University Medical Centers), Tom van der Poll(Amsterdam Neuroscience), M Hillebregt, Abraham Goorhuis, Gerben-Rienk Visser(Amsterdam UMC Location University of Amsterdam), Jantien van Berkel(Amsterdam UMC Location University of Amsterdam), D P Benschop(Amsterdam UMC Location University of Amsterdam), B C Elsenga(Amsterdam University Medical Centers), Solange Moll(University Hospital of Geneva), Neeltje A. Kootstra(Netherlands Institute for Neuroscience), F.J.B. Nellen(Stichting HIV Monitoring), Rosan A van Zoest, Suzanne E. Geerlings(Amsterdam University Medical Centers), Luuk Gras, A F Girigorie(Amsterdam UMC Location University of Amsterdam), M. Heidenrijk, Ferdinand W.N.M. Wit(Amsterdam UMC Location University of Amsterdam), Jan T. M. van der Meer(Amsterdam University Medical Centers), J. H. N. Schrijver(Amsterdam UMC Location University of Amsterdam), Ineke G. Stolte(Amsterdam UMC Location University of Amsterdam), M. M. Mangas Ruiz(Amsterdam UMC Location University of Amsterdam), Mieke H. Godfried, Lars Møller, Cris M. Welling(Amsterdam UMC Location University of Amsterdam), M. Wezel
Cited by 773
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k
Sepsis: a roadmap for future research
|The Lancet Infectious Diseases|2015|1k